A prediction model combining pretreatment radiomics tumor parameters with immune parameters such as PDL-1 expression and density of tumor-infiltrating lymphocytes and CD3 expression identified a favorable outcome group characterized by a favorable immune-activated state [106]. Here, CD274 is linked to neoplasm.